Urothelial Cancer Latest Advances
Find the Latest Research About Urothelial Cancer
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28845 publications
Retraction Notice: Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages.
Journal: Carcinogenesis
Published: October 30, 2026
Organoids for drug sensitivity prediction in urothelial carcinoma.
Journal: Pharmacogenomics
Published: October 30, 2026
Germline Testing in Upper Tract Urothelial Carcinoma: A Nationwide Claims-Based Analysis.
Journal: JCO oncology practice
Published: October 30, 2026
Time-dependent indirect comparison of enfortumab vedotin plus pembrolizumab and disitamab vedotin plus toripalimab in advanced urothelial carcinoma.
Journal: Journal of chemotherapy (Florence, Italy)
Published: October 29, 2026
Circulating Tumor DNA in High-Grade Upper Tract Urothelial Carcinoma After Surgical Resection.
Journal: The Journal of urology
Published: October 28, 2026
Skin toxicity and effectiveness of first-line enfortumab vedotin plus pembrolizumab for urothelial carcinoma: a prospective multicenter real-world study in Japan.
Journal: ESMO real world data and digital oncology
Published: October 25, 2026
Initial Enfortumab Vedotin Dose Reduction and Outcomes in Pretreated Advanced Urothelial Carcinoma.
Journal: JAMA network open
Published: October 22, 2026
Skin Toxic Effects and Survival With Enfortumab Vedotin-Pembrolizumab in Advanced Urothelial Carcinoma.
Journal: JAMA network open
Published: October 20, 2026
Editorial Comments to Oncological Outcomes and Safety Profiles of Adjuvant Nivolumab in Muscle-Invasive Urothelial Carcinoma.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: October 15, 2026
UROTHELIAL CARCINOMA WITH SARCOMATOID SUBTYPE OF THE BLADDER ACCOMPANIED BY TROUSSEAU'S SYNDROME: A CASE REPORT
Journal: Nihon Hinyokika Gakkai zasshi. The japanese journal of urology
Published: October 12, 2026
CORRELATION BETWEEN RELATIVE DOSE INTENSITY AND TREATMENT OUTCOMES OF ENFORTUMAB VEDOTIN IN PATIENTS WITH LOCALLY ADVANCED/METASTATIC UROTHELIAL CARCINOMA
Journal: Nihon Hinyokika Gakkai zasshi. The japanese journal of urology
Published: October 12, 2026
Last Updated: 11/08/2026